Vidyya Medical News Service
Volume 5 Issue 319 Published - 14:00 UTC 08:00 EST 15-Nov-2003 Next Update - 14:00 UTC 08:00 EST 16-Nov-2003
little clear gif used for spacer

FDA approves Ovcon 35 as the first chewable oral contraceptive tablet for women
On Friday, November 14, the FDA approved Ovcon 35, an oral, spearmint-flavored contraceptive tablet that can be chewed and swallowed. This new version of Ovcon 35, indicated for the prevention of pregnancy, provides one more alternative to the many types of oral contraceptives currently on the market. Ovcon 35 contains a progestin (norethindrone) and an estrogen (ethinyl estradiol) found in products that are already marketed.  more

FDA alerts U.S. residents about recall of Glaxo Smith Kline "Diskus" asthma medicines sold in Canada
As a precaution, the Food and Drug Administration (FDA) is alerting U.S. residents to the recent recall of certain GlaxoSmithKline "Diskus" medicines sold in Canada to treat asthma and chronic obstructive pulmonary disease (COPD). The three asthma products – Ventolin Diskus, Flovent Diskus, and Serevent Diskus -- were recalled in Canada November 12th, 2003, because the products "drug delivery system may not function properly and may deliver too little of the drug" or none at all. Canadian patients are being advised to return the affected product to the pharmacy or physician's office where it was obtained in order to get a replacement.  more


Breast cancer and the environment studies conducted and supported by the National Cancer Institute
The National Cancer Institute (NCI) is conducting and supporting a number of cutting-edge research studies to understand breast cancer risk factors in the environment. The studies aim to identify and assess risk factors, detect and quantify cancer-causing environmental exposures, explain mechanisms and pathways or processes that link exposures to cancer, and identify and evaluate genetic determinants of individual susceptibility to cancer.  more

Research reveals that genes control severity of heart failure
By screening the genomes of mice with heart failure, Duke University Medical Center researchers have discovered multiple stretches of DNA containing genes that modify the heart's pumping ability and survival with the disease. The findings could point researchers to genes that determine the severity of heart failure in patients, according to the Duke team.  more

Sickest minority of heart attack patients constitute majority of in-hospital deaths
An international "snapshot" of almost 5,600 heart attack patients has shown that while those who also have heart failure and/or a weak left pumping chamber represent about 42 percent of total heart attack patients, they account for 81.5 percent of the deaths in hospital, according to Duke University Medical Center cardiologists and their international colleagues.  more

little clear gif used for a space